BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu Q, Cao F, Tao J, Li X, Zheng SG, Pan HF. Pentraxin 3: A promising therapeutic target for autoimmune diseases. Autoimmun Rev 2020;19:102584. [PMID: 32534154 DOI: 10.1016/j.autrev.2020.102584] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Huang X, Yu Q, Zhang L, Jiang Z. Research progress on Mincle as a multifunctional receptor. International Immunopharmacology 2023;114:109467. [DOI: 10.1016/j.intimp.2022.109467] [Reference Citation Analysis]
2 Zhang H, Wang R, Wang Z, Wu W, Zhang N, Zhang L, Hu J, Luo P, Zhang J, Liu Z, Feng S, Peng Y, Liu Z, Cheng Q. Molecular insight into pentraxin-3: update advances in innate immunity, inflammation, tissue remodeling, diseases, and drug role. Biomedicine & Pharmacotherapy 2022. [DOI: 10.1016/j.biopha.2022.113783] [Reference Citation Analysis]
3 Samões B, Zen M, Abelha-Aleixo J, Gatto M, Doria A. Caveats and pitfalls in defining low disease activity in systemic lupus erythematosus. Autoimmun Rev 2022;21:103165. [PMID: 35931316 DOI: 10.1016/j.autrev.2022.103165] [Reference Citation Analysis]
4 Kojima Y, Uzawa A, Ozawa Y, Yasuda M, Onishi Y, Akamine H, Kawaguchi N, Himuro K, Noto YI, Mizuno T, Kuwabara S. Serum pentraxin 3 concentration correlates with disease severity in patients with myasthenia gravis. Clin Neurol Neurosurg 2022;220:107371. [PMID: 35878561 DOI: 10.1016/j.clineuro.2022.107371] [Reference Citation Analysis]
5 Rozovski U, Veletic I, Harris DM, Li P, Liu Z, Jain P, Manshouri T, Ferrajoli A, Burger JA, Bose P, Thompson PA, Jain N, Wierda WG, Verstovsek S, Keating MJ, Estrov Z. STAT3 Activates the Pentraxin 3 Gene in Chronic Lymphocytic Leukemia Cells. J Immunol 2022;208:2847-55. [PMID: 35595309 DOI: 10.4049/jimmunol.2101105] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Huang B, Li J, Zhao J. Screening and identification of potential biomarkers and therapeutic targets for systemic sclerosis-associated interstitial lung disease. Arch Rheumatol 2021;36:548-59. [PMID: 35382367 DOI: 10.46497/ArchRheumatol.2021.8625] [Reference Citation Analysis]
7 Liang T, Chen J, Xu G, Zhang Z, Xue J, Zeng H, Jiang J, Chen T, Qin Z, Li H, Ye Z, Nie Y, Zhan X, Liu C. STAT3 and SPI1, may lead to the immune system dysregulation and heterotopic ossification in ankylosing spondylitis. BMC Immunol 2022;23. [DOI: 10.1186/s12865-022-00476-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Nenow J, Balogh E, Feldman S. Emerging Treatment Regimens in Psoriasis: Are There Advantages Over Current Biologic Therapies? EMJ Dermatol 2021. [DOI: 10.33590/emjdermatol/21-00154] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Chen WJ, Yu X, Yuan XR, Chen BJ, Cai N, Zeng S, Sun YS, Li HW. The Role of IL-36 in the Pathophysiological Processes of Autoimmune Diseases. Front Pharmacol 2021;12:727956. [PMID: 34675805 DOI: 10.3389/fphar.2021.727956] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Bilici Salman R, Koca G, Gülbahar Ateş S, Yapar D, Babaoglu H, Satış H, Avanoglu Güler A, Karadeniz H, Ataş N, Küçük H, Akdemir ÜÖ, Haznedaroğlu Ş, Tufan A, Göker B, Paşaoğlu H, Atay LÖ, Öztürk MA. Diagnostic utility of serum biomarkers in large vessel vasculitis and their correlation with positron emission tomography. Mod Rheumatol 2021:roab074. [PMID: 34918110 DOI: 10.1093/mr/roab074] [Reference Citation Analysis]
11 Han MM, Yuan XR, Shi X, Zhu XY, Su Y, Xiong DK, Zhang XM, Zhou H, Wang JN. The Pathological Mechanism and Potential Application of IL-38 in Autoimmune Diseases. Front Pharmacol 2021;12:732790. [PMID: 34539413 DOI: 10.3389/fphar.2021.732790] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
12 Yan YM, Zheng JN, Wu LW, Rao QW, Yang QR, Gao D, Wang Q. Prediction of a Competing Endogenous RNA Co-expression Network by Comprehensive Methods in Systemic Sclerosis-Related Interstitial Lung Disease. Front Genet 2021;12:633059. [PMID: 34290731 DOI: 10.3389/fgene.2021.633059] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Xiang K, Xu Z, Hu YQ, He YS, Wu GC, Li TY, Wang XR, Ding LH, Zhang Q, Tao SS, Ye DQ, Pan HF, Wang DG. Circadian clock genes as promising therapeutic targets for autoimmune diseases. Autoimmun Rev 2021;20:102866. [PMID: 34118460 DOI: 10.1016/j.autrev.2021.102866] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
14 Grădișteanu Pîrcălăbioru G, Chifiriuc M, Stoica RA. SEVELAMER CARBONATE MODULATES THE NLRP3 AND NLRP6 INFLAMMASOME EXPRESSION IN PATIENTS WITH DIABETIC NEPHROPATHY. Roum Arch Microbiol Immunol 2021;80:125-132. [DOI: 10.54044/rami.2021.02.02] [Reference Citation Analysis]
15 Yang X, Zhang M, Xu S, Pan H, Leng R, Shuai Z. Single Immunoglobulin IL-1-Related Receptor (SIGIRR) Gene rs7396562 Polymorphism and Expression Level in Rheumatoid Arthritis. Biomed Res Int 2021;2021:6683148. [PMID: 34036103 DOI: 10.1155/2021/6683148] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Chang X, Li D, Liu C, Zhang Z, Wang T. Pentraxin 3 is a diagnostic and prognostic marker for ovarian epithelial cancer patients based on comprehensive bioinformatics and experiments. Cancer Cell Int 2021;21:193. [PMID: 33952272 DOI: 10.1186/s12935-021-01854-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
17 Zhao R, Luo S, Zhao C. The role of innate immunity in myasthenia gravis. Autoimmun Rev 2021;20:102800. [PMID: 33722749 DOI: 10.1016/j.autrev.2021.102800] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Wang P, Wu Q, Shuai ZW. Emerging role of ficolins in autoimmune diseases. Pharmacol Res 2021;163:105266. [PMID: 33127557 DOI: 10.1016/j.phrs.2020.105266] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]